Alleviation of experimental colitis by enhancing intestinal barrier function through exosomal miR‐181a. Decreased expression of inflammatory cytokines in serum, including TNF‐α, IL‐6, IL‐1b, IL‐17 and IL‐18. Here, IL1B is linked to colitis.